VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WOOF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WOOFPetco Health and Wellness Company, Inc.
$2.58$737M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWOOFFinancials

Petco Health and Wellness Company, Inc. (WOOF) Financials

8Y historyFree accessUpdated daily

Revenue growth has largely stalled with a marginal 0.2% increase in 2026Q1, while operating margins remain constrained by high overhead, peaking at only 2.9% in 2025Q2.

WOOF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Feb'25Feb'24Jan'23Jan'22Jan'21Feb'20Feb'19
Sales/Revenue5.97B5.96B6.12B6.26B6.04B5.81B4.92B4.43B4.39B
Revenue Growth %-1.2%-2.53%-2.22%3.63%3.94%18.03%10.95%0.96%-
Cost of Goods Sold3.66B3.66B3.79B3.9B3.61B3.38B2.81B2.53B2.49B
COGS % of Revenue-61.33%62%62.37%59.79%58.21%57.18%57.01%56.63%
Gross Profit2.3B2.31B2.32B2.35B2.43B2.43B2.11B1.91B1.9B
Gross Margin %38.48%38.67%38%37.63%40.21%41.79%42.82%42.99%43.37%
Gross Profit Growth %--0.83%-1.25%-3.02%0.02%15.18%10.5%0.09%-
Operating Expenses2.18B2.18B2.32B3.53B2.2B2.16B1.91B1.8B1.75B
OpEx % of Revenue-36.65%37.89%56.5%36.47%37.2%38.87%40.5%39.76%
Selling, General & Admin2.18B2.18B2.32B2.31B2.2B2.16B1.91B1.78B1.73B
SG&A % of Revenue-36.65%37.89%36.95%36.47%37.2%38.87%40.07%39.32%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses0001.22B00019M373.17M
Operating Income110.3M120.43M7.05M-1.18B225.56M266.07M194.42M110.6M-214.72M
Operating Margin %1.85%2.02%0.12%-18.87%3.74%4.58%3.95%2.49%-4.89%
Operating Income Growth %-1608.03%100.6%-623.28%-15.23%36.85%75.79%151.51%-
EBITDA305.77M317.14M-1.46M-979.53M419.39M438.5M369.26M284.14M-27.72M
EBITDA Margin %5.12%5.32%-0.02%-15.66%6.95%7.55%7.51%6.41%-0.63%
EBITDA Growth %4.3%21777.58%99.85%-333.56%-4.36%18.75%29.96%1124.94%-
D&A (Non-Cash Add-back)195.71M196.71M-8.51M200.78M193.83M172.43M174.84M173.54M187M
EBIT139.87M146.53M15.56M-1.17B213.92M279.79M177.53M110.94M-214.76M
Net Interest Income-122.95M-124.89M-139.82M-147.5M-100.61M-77.33M-218.43M-252.68M-243.32M
Interest Income6.44M6.3M3.71M3.4M1.03M62K653K335K420K
Interest Expense130.49M131.2M143.53M150.91M101.64M77.4M219.08M253.02M243.74M
Other Income/Expense-120.02M-105.1M-116.35M-127.51M-100.3M-52.79M-235.98M-250.24M-243.78M
Pretax Income8.68M15.33M-109.3M-1.31B125.26M213.28M-41.55M-139.64M-458.5M
Pretax Margin %0.15%0.26%-1.79%-20.91%2.08%3.67%-0.84%-3.15%-10.44%
Income Tax3.1M6.27M-7.48M-27.61M35.35M53.47M-3.34M-35.66M-45.84M
Effective Tax Rate %35.7%40.87%6.84%2.11%28.22%25.07%8.03%25.54%10%
Net Income-23.54M9.07M-101.82M-1.28B90.8M164.42M-26.48M-95.87M-413.79M
Net Margin %-0.39%0.15%-1.66%-20.47%1.5%2.83%-0.54%-2.16%-9.42%
Net Income Growth %16.53%108.9%92.05%-1509.91%-44.77%720.84%72.38%76.83%-
Net Income (Continuing)5.58M9.07M-101.82M-1.28B89.91M159.81M-38.22M-103.98M-413.79M
Discontinued Operations000000000
Minority Interest00000-18.2M-13.58M-8.33M0
EPS (Diluted)-0.080.03-0.37-4.780.340.62-0.13-0.07-0.28
EPS Growth %18.91%108.57%92.26%-1505.88%-45.16%576.92%-97.87%76.54%-
EPS (Basic)-0.03-0.37-4.780.340.62-0.13-0.07-0.28
Diluted Shares Outstanding283.68M286.15M273.41M267.55M265.95M265.34M210.68M1.46B1.46B
Basic Shares Outstanding283.68M279.56M273.41M267.55M265.52M265.19M203.72M1.44B1.46B
Dividend Payout Ratio---------

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

High fixed-cost operating leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stagnant Revenue Amid Market Saturation

As reported in recent financial filings, Petco's revenue growth has stalled, with the most recent quarter showing a marginal 0.2% increase following several periods of contraction, suggesting that the post-pandemic demand surge has fully dissipated and organic growth remains elusive in a highly competitive retail environment.

The company's inability to consistently grow top-line revenue indicates that its physical footprint and service-led strategy are struggling to capture incremental market share. Investors should monitor whether this stagnation reflects a fundamental loss of pricing power or a broader consumer trade-down away from premium pet offerings.

Gross Margin Volatility Limits Profitability

Based on the provided income statement data, gross margins have fluctuated between 34.7% and 39.3% over the last ten quarters, highlighting the difficulty in maintaining consistent profitability while balancing high-margin service offerings against the lower-margin, price-sensitive consumables segment that dominates the company's total revenue mix.

The inconsistency in gross margin performance suggests that Petco lacks the structural pricing power to fully offset inflationary pressures or competitive discounting. This volatility complicates the path to sustainable net profitability, as the company remains tethered to the margin-dilutive nature of its core retail business.

Operating Leverage Constrained by Overhead

According to the quarterly income statement, operating income remains razor-thin, peaking at only 2.9% in 2025Q2, which demonstrates that the company's high fixed-cost structure prevents meaningful operating leverage even when gross profit margins show temporary improvement during specific periods of the fiscal year.

The persistent burden of SG&A expenses relative to gross profit suggests that the company's physical infrastructure and corporate overhead are not scaling efficiently. This lack of operating leverage implies that any minor disruption in foot traffic or service utilization could quickly push the firm into an operating loss position.

Persistent Net Losses Undermine Quality

As indicated by the historical income data, Petco has reported net losses in eight of the last ten quarters, revealing that despite positive operating income in several periods, the company's bottom line is consistently eroded by non-operating costs and the high expense of maintaining its service-heavy business model.

The recurring nature of these net losses warrants further investigation into the company's capital structure and interest obligations. Investors should be cautious, as the reported earnings quality appears weak, with net income failing to reflect the operational scale the company has attempted to build through its clinic expansion.

Structural Risks to Platform Strategy

Based on an analysis of the provided figures, short-sellers would likely focus on the company's inability to achieve consistent net profitability despite significant investment in veterinary services, suggesting that the 'platform' strategy may be failing to generate the expected high-margin recurring revenue needed to offset retail headwinds.

The core risk remains that the veterinary and grooming services are not effectively converting customers into high-margin, long-term brand loyalists. If the service-to-retail attachment rate does not improve, the company may be forced to reconsider its capital-intensive expansion, potentially leading to further balance sheet strain.

WOOF — Frequently Asked Questions

Quick answers to the most common questions about buying WOOF stock.

What was Petco Health and Wellness Company, Inc.'s (WOOF) revenue in 2025?

For fiscal year 2025, Petco Health and Wellness Company, Inc. (WOOF) reported total revenue of $5.96B. This represents a 35.7% increase compared to $4.39B in 2018.

Is Petco Health and Wellness Company, Inc. (WOOF) profitable?

Petco Health and Wellness Company, Inc. (WOOF) is profitable, generating $9.1M in net income for the fiscal year ending 2025 with a net profit margin of 0.2%.

What is Petco Health and Wellness Company, Inc.'s operating profit margin?

Petco Health and Wellness Company, Inc. (WOOF) reported an operating income of $120.4M, resulting in an operating profit margin of 2.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Petco Health and Wellness Company, Inc.'s gross profit and gross margin?

Petco Health and Wellness Company, Inc. (WOOF) generated $2.31B in gross profit for the year, representing a gross profit margin of 38.7%. This demonstrates the company's core pricing power and production efficiency.